Clinical SpotlightSM on Metastatic Colorectal Cancer from the 2012 Gastrointestinal
Cancer Meeting in San Francisco
prIME Oncology invites you to view an expert interview, eNewsflash, and downloadable slides regarding exciting new data released at the 2012 Annual Gastrointestinal Cancer Meeting in San Francisco.
23 January 2012
View an expert discussion with Alberto Sobrero, MD, and Edith Mitchell, MD, FACP, regarding exciting new data released on metastatic colorectal cancer. Topics include:
Results from VELOUR: A phase III study of aflibercept versus placebo in combination with FOLFIRI for the treatment of patients with previously treated metastatic colorectal cancer
Abstract #547: Observational study describing bevacizumab use and outcomes among metastatic colorectal cancer patients receiving care in the outpatient community in the United States
Abstract #561: Meta-analysis of anti VEGF class adverse events from 3 double-blind (Db) placebo (Pbo) controlled phase 3 trials with IV aflibercept
LEARNING OBJECTIVES
Upon completion of this educational activity, participants should be able to:
Evaluate emerging clinical trial data pertaining to metastatic colorectal cancer, and evaluate how this data should be incorporated into current standards of care to improve patient outcomes
Discuss the rationale and utility of novel agents or combination strategies that may provide superior disease outcomes for patients with metastatic colorectal cancer compared to current standards of care
